| __timestamp | ADMA Biologics, Inc. | Gilead Sciences, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 9517014 | 2854000000 |
| Thursday, January 1, 2015 | 7015946 | 3014000000 |
| Friday, January 1, 2016 | 7688238 | 5098000000 |
| Sunday, January 1, 2017 | 6229587 | 3734000000 |
| Monday, January 1, 2018 | 3926120 | 5018000000 |
| Tuesday, January 1, 2019 | 2343848 | 9106000000 |
| Wednesday, January 1, 2020 | 5907013 | 5039000000 |
| Friday, January 1, 2021 | 3646060 | 5363000000 |
| Saturday, January 1, 2022 | 3613764 | 4977000000 |
| Sunday, January 1, 2023 | 3300000 | 6923000000 |
| Monday, January 1, 2024 | 5907000000 |
Unlocking the unknown
In the competitive world of biotechnology, investment in research and development (R&D) is crucial for staying ahead. Over the past decade, Gilead Sciences, Inc. and ADMA Biologics, Inc. have shown contrasting approaches to innovation. Gilead Sciences, a leader in the field, consistently invests significantly more in R&D, with expenditures peaking at approximately $9.1 billion in 2019. This represents a staggering 1,000% more than ADMA Biologics' highest annual investment of around $9.5 million in 2014.
Despite the disparity, both companies have shown commitment to innovation, albeit on different scales. Gilead's robust R&D spending underscores its strategy to maintain a competitive edge, while ADMA's more modest investments reflect its focused approach. As the biotech landscape evolves, these investment strategies will play a pivotal role in shaping the future of healthcare innovation.
Analyzing R&D Budgets: Gilead Sciences, Inc. vs Bio-Techne Corporation
Research and Development Investment: Gilead Sciences, Inc. vs Halozyme Therapeutics, Inc.
Research and Development Expenses Breakdown: Gilead Sciences, Inc. vs Lantheus Holdings, Inc.
R&D Spending Showdown: Gilead Sciences, Inc. vs TG Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Gilead Sciences, Inc. and Xencor, Inc.
Who Prioritizes Innovation? R&D Spending Compared for argenx SE and ADMA Biologics, Inc.
R&D Insights: How Bio-Techne Corporation and ADMA Biologics, Inc. Allocate Funds
BioMarin Pharmaceutical Inc. vs ADMA Biologics, Inc.: Strategic Focus on R&D Spending
R&D Insights: How Madrigal Pharmaceuticals, Inc. and ADMA Biologics, Inc. Allocate Funds
Research and Development Expenses Breakdown: Ionis Pharmaceuticals, Inc. vs ADMA Biologics, Inc.
Research and Development Investment: Alkermes plc vs ADMA Biologics, Inc.
Research and Development: Comparing Key Metrics for TG Therapeutics, Inc. and ADMA Biologics, Inc.